Phase III randomized study of chemotherapy with MTX [methotrexate] vs EDAM [edatrexate] (a new MTX analogue) in patients with advanced squamous cell carcinoma of the head and neck
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2006
At a glance
- Drugs Edatrexate (Primary) ; Methotrexate
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 04 Oct 2006 New trial record.